|
|
Volumn 11, Issue 1, 2012, Pages 14-15
|
|
Mark Fishman
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANAKINUMAB;
MONOCLONAL ANTIBODY;
CINCA SYNDROME;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG RESEARCH;
GENE SEQUENCE;
GOUT;
NOTE;
PRIORITY JOURNAL;
RARE DISEASE;
REGENERATIVE MEDICINE;
ARTICLE;
CELL DIFFERENTIATION;
CYTOLOGY;
DRUG DEVELOPMENT;
DRUG EFFECT;
HUMAN;
IMMUNOLOGY;
INTERVIEW;
METHODOLOGY;
SIGNAL TRANSDUCTION;
STEM CELL;
ANTIBODIES, MONOCLONAL;
CELL DIFFERENTIATION;
DRUG DISCOVERY;
DRUG INDUSTRY;
HUMANS;
SIGNAL TRANSDUCTION;
STEM CELLS;
|
|
EID: 84855370158
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3640 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|